homepage home
subscribe to California Construction magazine subscribe
newsletters free e-newsletter
advertise
industry jobs industry jobs
Dodge Data & Analytics
California Construction Logo
Order Your RISK FREE Subscription
comment

Taisei Completes Pharmaceutical Plant in Riverside County

Text size: A A

Taisei Construction Corp., Cypress, recently completed a 53,000-sq-ft herbal healthcare supplements plant in the western Riverside County community of Mira Loma for Wakunaga of America. The construction phase spanned 11 months and was finished one month early.

Taisei Completes Pharmaceutical Plant in Riverside County
----- Advertising -----

The five-acre plant, located at the intersection of East Philadelphia Avenue and Venture Drive, represents a major expansion of an eight-acre site occupied by Wakunaga since 1992. The new tilt-up-concrete facility has 29,000 sq ft of production space, 11,400 sq ft of office space and about 12,500 sq ft of warehouse space.

Wakunaga already has a 23,000-sq-ft plant on a contiguous 2.3 acres. That plant will remain operational. Wakunaga will continue to age its garlic at the Mira Loma site and retain its corporate office in Mission Viejo.

Peter Tuma, Taisaiís vice president/construction, says the project, one of the few of its kind to be built in inland Southern California in the last year, created about 200 construction jobs. Wakunaga expects to have about 100 employees working in the new plant in the next year or so.

In addition to Tuma, Taiseiís project team included Warren Lee, manager; Mario Morales, shell superintendent; and Garrett Lumbattis, interiors superintendent. The architect for the project was Ware Malcomb, Irvine.

----- Advertising -----
New Blog: Vertically Speaking in Northern California
New Blog: Field Notes
Reader Photos
Photos from California Construction Photo Showcase
Dodge Lead Center
Search for local construction projects OR CALL 877-234-4246 and get a FREE Lead Now!
Search by Project Type & State





----- Advertising -----
 Reader Comments:

Sign in to Comment

To write a comment about this story, please sign in. If this is your first time commenting on this site, you will be required to fill out a brief registration form. Your public username will be the beginning of the email address that you enter into the form (everything before the @ symbol). Other than that, none of the information that you enter will be publically displayed.

We welcome comments from all points of view. Off-topic or abusive comments, however, will be removed at the editors’ discretion.